These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1604 related items for PubMed ID: 8440914

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
    Skender-Kalnenas TM, English DR, Heenan PJ.
    J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
    [Abstract] [Full Text] [Related]

  • 3. Increased intraepidermal melanocyte frequency and size in dysplastic melanocytic nevi and cutaneous melanoma. A comparative quantitative study of dysplastic melanocytic nevi, superficial spreading melanoma, nevocellular nevi, and solar lentigines.
    Rhodes AR, Melski JW, Sober AJ, Harrist TJ, Mihm MC, Fitzpatrick TB.
    J Invest Dermatol; 1983 May; 80(5):452-9. PubMed ID: 6341476
    [Abstract] [Full Text] [Related]

  • 4. Melanocytic lesions in a private pathology practice. Comparison of histologic features in different tumor types with particular reference to dysplastic nevi.
    Hastrup N, Hou-Jensen K.
    APMIS; 1993 Nov; 101(11):845-50. PubMed ID: 8286092
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS, Shakhtour B, Shyr Y.
    J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cutaneous melanoma histologically associated with a nevus and melanoma de novo have a different profile of risk: results from a case-control study.
    Carli P, Massi D, Santucci M, Biggeri A, Giannotti B.
    J Am Acad Dermatol; 1999 Apr; 40(4):549-57. PubMed ID: 10188672
    [Abstract] [Full Text] [Related]

  • 11. The malignant potential of small congenital nevocellular nevi. An estimate of association based on a histologic study of 234 primary cutaneous melanomas.
    Rhodes AR, Sober AJ, Day CL, Melski JW, Harrist TJ, Mihm MC, Fitzpatrick TB.
    J Am Acad Dermatol; 1982 Feb; 6(2):230-41. PubMed ID: 7061746
    [Abstract] [Full Text] [Related]

  • 12. Melanocytic nevi simulant of melanoma with medicolegal relevance.
    Massi G.
    Virchows Arch; 2007 Sep; 451(3):623-47. PubMed ID: 17653760
    [Abstract] [Full Text] [Related]

  • 13. Cutaneous melanomas associated with nevi.
    Bevona C, Goggins W, Quinn T, Fullerton J, Tsao H.
    Arch Dermatol; 2003 Dec; 139(12):1620-4; discussion 1624. PubMed ID: 14676081
    [Abstract] [Full Text] [Related]

  • 14. Cell kinetics of melanocytes in common and dysplastic nevi and in primary and metastatic cutaneous melanoma.
    Urso C, Bondi R, Balzi M, Scubla E, Mauri P, Becciolini A, Tarocchi S, Vallecchi C.
    Pathol Res Pract; 1992 Apr; 188(3):323-9. PubMed ID: 1625997
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.
    Clark WH, Elder DE, Guerry D, Epstein MN, Greene MH, Van Horn M.
    Hum Pathol; 1984 Dec; 15(12):1147-65. PubMed ID: 6500548
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunohistochemical expression of VEGF, HIF1-a, and PlGF in malignant melanomas and dysplastic nevi.
    Konstantina A, Lazaris AC, Ioannidis E, Liossi A, Aroni K.
    Melanoma Res; 2011 Oct; 21(5):389-94. PubMed ID: 21876459
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 81.